Climb Bio (CLYM) Other Non-Current Assets (2020 - 2026)
Climb Bio (CLYM) recorded Other Non-Current Assets of $1.65 million in Q2 2026, up 20.5% from $1.37 million a year earlier and up 7.8% from the prior quarter.
Analysis
Climb Bio (CLYM) Other Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Climb Bio reported Other Non-Current Assets of $1.53 million.
- Annual Other Non-Current Assets has a five-year compound annual growth rate of -10.3% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Assets came in at $16,000 in FY2024 (-85.7%), $112,000 in FY2023 (-75.4%), $456,000 in FY2022 (-46.5%) and $852,000 in FY2021 (-67.6%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Assets since Q2 2023.
- On a year-over-year basis, Other Non-Current Assets rose in four of the last seven quarters, with growth averaging 118.3%.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 577.0% in Q1 2026, against a decline of 85.7% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.53 million (Q1 2026), $1.53 million (Q4 2025) and $1.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Climb Bio | 823.99 Mn | 343.32 Mn | - | 1.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.65 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 340,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | 361,000.00 |
| Jun 30, 2024 | 696,000.00 |
| Mar 31, 2024 | 625,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Sep 30, 2023 | 616,000.00 |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 584,000.00 |
| Sep 30, 2022 | 696,000.00 |
| Jun 30, 2022 | 4.63 Mn |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 922,000.00 |
| Sep 30, 2021 | 1.05 Mn |
API Access
Climb Bio Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CLYM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "CLYM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CLYM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();